ArtNr |
HY-100490A-5mg |
Hersteller |
MedChem Express
|
CAS-Nr. |
207572-68-7 |
Menge |
5 mg |
Quantity options |
100 mg
10 mg
25 mg
50 mg
5 mg
|
Kategorie |
|
Typ |
Inhibitors |
Specific against |
other |
Purity |
99.82 |
Formula |
C10H16N2O.1/2C4H4O4 |
Citations |
[1]Reid JL. Rilmenidine: a clinical overview. Am J Hypertens. 2000;13(6 Pt 2):106S-111S.<br/>[2]Srdic-Rajic T, et al. Rilmenidine suppresses proliferation and promotes apoptosis via the mitochondrial pathway in human leukemic K562 cells. Eur J Pharm Sci. 2016;81:172-180.<br/>[3]Rose C, et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Genet. 2010;19(11):2144-2153. |
Smiles |
O=C(O)/C=C/C(O)=O.C1(NC(C2CC2)C3CC3)=NCCO1 |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
207572-68-7 |
Similar products |
207572-68-7 |
Lieferbar |
|
Product Description |
Rilmenidine hemifumarate, an innovative antihypertensive agent, is an orally active, selective I1 imidazoline receptor agonist. Rilmenidine hemifumarate is an alpha 2-adrenoceptor agonist. Rilmenidine hemifumarate induces autophagy. Rilmenidine hemifumarate acts both centrally by reducing sympathetic overactivity and in the kidney by inhibiting the Na+/H+ antiport. Rilmenidine hemifumarate modulates proliferation and stimulates the proapoptotic protein Bax thus inducing the perturbation of the mitochondrial pathway and apoptosis in human leukemic K562 cells [1][2][3]. |
StorageTemperature |
-20°C (Powder, stored under nitrogen, away from moisture) |
Shipping |
Blue Ice |
Manufacturers Applications |
Cancer-programmed cell death |
MolecularWeight |
238.28 |
Clinical Information |
Launched |
Manufacturers Research Area |
Cancer; Cardiovascular Disease |
Solubility |
DMSO : 10 mg/mL (ultrasonic)|H2O : 50 mg/mL (ultrasonic) |
Target |
Adrenergic Receptor; Apoptosis; Autophagy; Imidazoline Receptor |
Manufacturers Target |
Adrenergic Receptor; Apoptosis; Autophagy; Imidazoline Receptor |
Manufacturers Pathway |
Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling |
Manufacturers Product type |
Reference compound |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.